Ciulla Thomas
- SEC CIK
- 0001815426
No open-market purchases or sales filed in the past year.
Current role at each company
- VRDN Viridian Therapeutics, Inc.Chief Medical Officeras of Feb 7, 2024
- CLSD Clearside Biomedical, Inc.Chief Medical Officeras of Jan 20, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Ciulla Thomas as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CLSD Clearside Biomedical, Inc.
Chief Medical Officer4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 20, 2023 (view filing) | Jan 20 | Same day | Ciulla ThomasChief Medical Officer | SSale | −13.7K | $1.47 | −$20.1K | −4.5%291.9K after | |
| Jan 11, 2023 (view filing) | Jan 10 | 1 day | Ciulla ThomasChief Medical Officer | SSale | −2.17K | $1.62 | −$3.52K | −0.7%305.6K after | |
| Jan 20, 2022 (view filing) | Jan 19 | 1 day | Ciulla ThomasChief Medical Officer | SSale | −9.05K | $2.13 | −$19.3K | −3.0%295.3K after | From original |
| Sep 23, 2021 (view filing) | Sep 21 | 2 days | Ciulla ThomasChief Medical Officer | SSale | −2.56K | $6.40 | −$16.4K | −1.0%255.6K after |